Does TENOFOVIR DISOPROXIL Cause Condition aggravated? 224 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 224 reports of Condition aggravated have been filed in association with TENOFOVIR DISOPROXIL (Tenofovir Disoproxil Fumarate). This represents 0.8% of all adverse event reports for TENOFOVIR DISOPROXIL.
224
Reports of Condition aggravated with TENOFOVIR DISOPROXIL
0.8%
of all TENOFOVIR DISOPROXIL reports
82
Deaths
88
Hospitalizations
How Dangerous Is Condition aggravated From TENOFOVIR DISOPROXIL?
Of the 224 reports, 82 (36.6%) resulted in death, 88 (39.3%) required hospitalization, and 12 (5.4%) were considered life-threatening.
Is Condition aggravated Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TENOFOVIR DISOPROXIL. However, 224 reports have been filed with the FAERS database.
What Other Side Effects Does TENOFOVIR DISOPROXIL Cause?
Bone density decreased (10,586)
Renal injury (9,255)
Skeletal injury (8,320)
Chronic kidney disease (7,230)
Osteonecrosis (7,182)
Bone loss (7,040)
Multiple fractures (6,793)
Renal failure (6,388)
Osteoporosis (5,302)
Tooth loss (4,483)
What Other Drugs Cause Condition aggravated?
TOFACITINIB (16,925)
INFLIXIMAB (16,616)
DUPILUMAB (16,459)
ETANERCEPT (15,897)
METHOTREXATE (14,938)
ADALIMUMAB (13,527)
PREDNISONE (10,751)
INFLIXIMAB-DYYB (10,275)
HYDROXYCHLOROQUINE (8,848)
RITUXIMAB (8,627)
Which TENOFOVIR DISOPROXIL Alternatives Have Lower Condition aggravated Risk?
TENOFOVIR DISOPROXIL vs TEPLIZUMAB-MZWV
TENOFOVIR DISOPROXIL vs TEPOTINIB
TENOFOVIR DISOPROXIL vs TEPROTUMUMAB
TENOFOVIR DISOPROXIL vs TEPROTUMUMAB-TRBW
TENOFOVIR DISOPROXIL vs TERAZOSIN